Form 4: Boston Scientific CEO Michael Mahoney Executes Stock Options and Sells Shares Under 10b5-1 Plan
SEC Form 4 Filing
Michael Mahoney, Chairman, President & CEO of Boston Scientific, exercised stock options and sold shares of common stock on November 5, 2024, according to a pre-established Rule 10b5-1 trading plan.
Summary
- Michael F. Mahoney, Chairman, President & CEO of Boston Scientific, executed stock options and sold shares of common stock on November 5, 2024.
- The transactions were carried out under a pre-established Rule 10b5-1 trading plan adopted on February 28, 2024.
- Mahoney exercised options to acquire 56,211 shares at $17.26 and 55,676 shares at $16.31.
- He then sold 2,596 shares at a weighted average price of $85.1727 and 160,182 shares at a weighted average price of $84.7395.
- Following these transactions, Mahoney directly owns 1,521,205 shares of common stock and indirectly owns 209,278 shares through a trust.
- He also holds options to purchase 168,635 shares of common stock at $17.26 and no options at $16.31.
Sentiment
Score: 5
Explanation: The document is a standard SEC filing detailing stock transactions by an executive. It doesn't inherently convey positive or negative sentiment, but rather provides factual information.
Industry Context
Executive stock transactions are a common occurrence in publicly traded companies. Rule 10b5-1 plans allow insiders to sell shares over a predetermined period, avoiding accusations of trading on non-public information.
Stakeholder Impact
- The stock sale may have a minor impact on shareholders due to the increased supply of shares in the market.
Key Dates
| Date | Description |
|---|---|
| 02/28/2024 | Date of adoption of the Rule 10b5-1 trading plan |
| 11/05/2024 | Date of the reported transactions (option exercise and stock sale) |
| 02/23/2025 | Expiration date of stock options for 55,676 shares |
| 02/22/2026 | Expiration date of stock options for 56,211 shares |
| 11/07/2024 | Date of signature of the Form 4 filing |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.